10 results match your criteria: "The International Diabetes Center[Affiliation]"
Continuous Glucose Monitoring-Derived Differences in Pregnancies With and Without Adverse Perinatal Outcomes.
Obstet Gynecol
November 2024
Maternal Fetal Medicine Research Program, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; the Jaeb Center for Health Research, Tampa, Florida; and the International Diabetes Center, HealthPartners Institute, St. Louis Park, Minnesota.
Objective: To evaluate whether continuous glucose monitoring (CGM)-derived glycemic patterns observed throughout pregnancy were associated with adverse perinatal outcomes, specifically fetal growth disorders and hypertensive disorders of pregnancy (HDP).
Methods: We conducted a prospective observational study of individuals with viable singleton pregnancies and screening hemoglobin A 1c levels less than 6.5%.
Diabetes self-management education and support in adults with type 2 diabetes: A consensus report of the American Diabetes Association, the Association of Diabetes Care and Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association.
JAAPA
July 2020
Margaret A. Powers is a senior consultant with the nutrition practice and evaluation services at HealthPartners in Bloomington, Minn., and at the time this article was started, was a research scientist at the International Diabetes Center at Park Nicollet Helath Services in Minneapolis, Minn. Joan K. Bardsley is an assistant vice president of research and nursing integration with Medstar Health Research Institute and MedStar Health System Nursing in Hyattsville and Columbia, Md. Marjorie Cypress is an independent consultant in Albuquerque, N.M. Martha M. Funnell is an emeritus research scientist in the Department of Learning Health Science at the University of Michigan Medical School in Ann Arbor, Mich. Dixie Harms is a family NP at MercyOne Clive (Iowa) Internal Medicine. Amy Hess-Fischl is program manager and diabetes care and education specialist in the Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism at the University of Chicago in Chicago, Ill. Beulette Hooks is at Martin Army Community Hospital in Fort Benning, Ga. Diana Isaacs is an endocrine clinical pharmacy specialist at the Cleveland (Ohio) Clinic Diabetes Center. Ellen D. Mandel is program director and a professor in the PA program at Johnson & Wales University in Providence, R.I. Melinda D. Maryniuk is the owner of Maryniuk & Associates in Boston, Mass. Anna Norton is chief executive officer of DiabetesSisters in Chicago, Ill. Joanne Rinker is director of practice and content development in the science and practice department at the Association of Diabetes Care & Education Specialists in Chicago, Ill. Linda M. Siminerio is a professor of medicine and nursing, health and community systems at the University of Pittsburgh in Pittsburgh, Pa. Sacha Uelmen is director of diabetes education and prevention programs at the Association of Diabetes Care & Education Specialists in Chicago, Ill. This article was funded by the ADA and the Association of Diabetes Care & Education Specialists. Margaret A. Powers discloses research funding from Abbott Nutrition, is a senior advisor for ADA's Nutrition Interest Group, and is a member of ADA/American Heart Association Science Advisory Group for Know Diabetes by Heart. Joan K. Bardsley reports being a past chair of the Certification Board for Diabetes Care and Education, is the program chair for the Association of Diabetes Care & Education Specialists annual meeting, and has been a consultant to Joslin Diabetes Center. Martha M. Funnell is on an advisory board of Eli Lilly. Dixie Harms is the treasurer for the American Academy of Nurse Practitioners Certification Board of Commissioners and Vice President of the American Nurse Practitioner Foundation. Amy Hess-Fischl reports receiving an honorarium from ADA as an Education Recognition Program auditor and is a participant in a speakers bureau sponsored by Abbott Diabetes Care and Xeris. Diana Isaacs reports being a participant in a speakers bureau/consultant for Xeris Pharmaceuticals, Novo Nordisk, Dexcom, and Lifescan. Melinda D. Maryniuk reports being a paid consultant of Diabetes-What to Know, Arkray, and DayTwo. Anna Norton reports being a participant in speakers bureaus sponsored by Boehringer Ingelheim, Novo Nordisk, and Xeris. Linda M. Siminerio reports research grant funding from Becton Dickinson. Sacha Uelmen has received honoraria from ADA. The authors have disclosed no other potential conflicts of interest, financial or otherwise.
Purpose: To describe the benefits of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) systems compared with self-monitoring of blood glucose (SMBG) and multiple daily injection (MDI) therapy; to assess the benefits of sensor-augmented pump therapy (SAPT) in patients with type 1 diabetes; and to present an evidence-based practical protocol for introducing SAPT in patients with no prior pump or CGM experience.
Conclusion: Continuous glucose monitoring and CSII have advantages over SMBG and MDI, respectively, in terms of A1C and hypoglycemia reduction. The Sensor-Augmented Pump Therapy for A1C Reduction (STAR) 3 trial demonstrated that initiating both CGM and CSII in selected adult and pediatric patients with type 1 diabetes unable to meet glycemic goals with intensive insulin injection therapy significantly improved glucose control.
Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey.
Diabetes Educ
June 2011
Global Medical Affairs, Novo Nordisk A/S, Bagsvaerd, Denmark (Dr Nazeri)
Purpose: The purpose of this study was to investigate the opinions of primary care physicians (PCPs) and diabetes specialists on their perceived role in tackling type 2 diabetes (T2D) and the challenges they face, particularly regarding insulin intensification.
Methods: Six hundred physicians from Germany, Japan, Spain, Turkey, the United Kingdom, and the United States were recruited to complete an online survey. Screening criteria included T2D patients seen per week (Europe/Japan: all ≥ 2; United States: PCPs ≥ 5; specialists ≥ 10) and years in practice (3-30 years).
Development of the American Association of Diabetes Educators' Diabetes Self-management Assessment Report Tool.
Diabetes Educ
March 2008
The International Diabetes Center, Park Nicollet Health System, Minneapolis, Minnesota (at the initiation of this research, now with Medtronic, Inc; Dr Weaver).
Purpose: The purpose of this article is to describe the development and testing of a new tool for collecting patient information for diabetes self-management education (DSME): the Diabetes Self-management Assessment Report Tool (D-SMART). The D-SMART was designed through expert panel consensus based on a hybrid conceptual framework and is intended to serve multiple functions at the level of the patient, the program, and the field.
Methods: The D-SMART has completed 3 rounds of pilot testing and is currently undergoing a fourth round, with each round resulting in revisions to the original instrument.
Purpose: The purpose of this study was to evaluate the impact of a tobacco cessation intervention using motivational interviewing on smoking cessation rates during diabetes self-management training (DSMT).
Methods: A randomized controlled trial was conducted with subjects recruited from an ongoing type 2 diabetes adult education program at a large diabetes center. A total of 114 subjects were randomized to intervention (n = 57; face-to-face motivational interviewing plus telephone counseling and offering of medication) or standard care (n = 57).
Systematically initiating insulin: the staged diabetes management approach.
Diabetes Educ
March 2006
The International Diabetes Center, Minneapolis, Minnesota
Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy.
Diabetes Educ
April 2002
The International Diabetes Center, Park Nicollet Institute, Minneapolis (Dr Bergenstal and Mss Pearson, Bina, Davidson, and List)
Purpose: This study was conducted to evaluate patients' proficiency in self-monitoring of blood glucose (SMBG).
Methods: Diabetes nurse educators in 4 suburban Minneapolis clinic sites surveyed the SMBG training/cure practices of 280 patients with type 1 and type 2 diabetes. Participant SMBG technique was measured by direct observation.
National Diabetes Education Outcomes System: application to practice.
Diabetes Educ
April 2002
The International Diabetes Center, Minneapolis, Minnesota (Mr. Weaver)
Diabetes education outcomes: what educators are doing.
Diabetes Educ
April 2002
Inova Diabetes Center, Fairfax, Virginia (Mss Mulcahy and Peeples)